In this three-part podcast series, hear from seasoned experts from Allucent as they discuss a range of topics, including how small and mid-sized companies can take a more strategic approach to pharmacovigilance, a regulatory & development roadmap for antibody drug conjugates (ADCs) and radionuclide drug conjugates (RDCs), and the use of artificial intelligence in clinical trials and Good Clinical Practice (GCP) compliance.
Check out the podcast episodes below.
⬆- Ep. 3 Artificial Intelligence, GCP Compliance, & Inspection Readiness in Clinical Trials
- Ep. 2 Advancing Oncology Research: Regulatory & Development Path for ADCs & RDCs
- Ep. 1 Strategic Alliances in the Development and Execution of Pharmacovigilance Strategy
Ep. 3
Artificial Intelligence, GCP Compliance, & Inspection Readiness in Clinical Trials
In our third episode, we’ll explore how artificial intelligence (AI) is transforming clinical trials in biotech, impacting Good Clinical Practice (GCP) compliance, and inspection readiness. You’ll learn about AI applications in trial design, participant adherence, and data quality, and discover strategies to ensure regulatory compliance.
Ep. 2
Advancing Oncology Research: Regulatory & Development Path for ADCs & RDCs
Join us in our second episode of “Partner for Progress: Strategies for Biotech Success”, where we delve into the world of antibody drug conjugates (ADCs) and radionuclide conjugates (RDCs). We’ll explore the tremendous growth potential of these targeted oncology therapies, the challenges faced by small and mid-sized biotech companies, and strategies for navigating the complex regulatory landscape.
Ep. 1
Strategic Alliances in the Development and Execution of Pharmacovigilance Strategy
In this inaugural episode of Partner for Progress: Strategies for Biotech Success, Ian Kovacs, the Global Head of Pharmacovigilance at Allucent discusses how small & mid-sized companies can efficiently manage pharmacovigilance. We’ll discuss why partnering early is key to your pharmacovigilance strategy – and to delivering products to the patients who need them.
